TALK-UNCT07325617
Tracking AI/LLM Literacy and Knowledge in Urology Outpatients (TALK-U)
StatusCompleted
PhaseNot specified
Primary completion
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 2 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria expanded, about 9 words Show 5 more changesShow less
- Completed without a posted recruiting period
- Final enrollment: 1005 participants (planned 400)
- Secondary endpoints: details revised at 1 of 3 entries
- Site contact updated
- Study description shortened, about 2 words
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Pre-visit Anxiety (VAS 0-10)
Timeframe: Day 0 (immediately before the outpatient visit)
Secondary (3)
Post-visit Anxiety (VAS 0-10)
Visit Satisfaction (VAS 0-10)
Disease Awareness/Understanding (VAS 0-10)
Arms and interventions
AI/LLM users
Participants who report prior use of AI chat tools based on large language models (e.g., ChatGPT or similar) for health information before the outpatient urology visit, as assessed by the study questionnaire.
non AI/LLM users
Participants who report no prior use of AI/LLM chat tools (e.g., ChatGPT or similar) for health information before the outpatient urology visit, as assessed by the study questionnaire.
Sites
1 site in 1 country
- Dr.Abdurrahman Yurtaslan Ankara Oncology Research and Training HospitalAnkara, Yenimahalle/Ankara, Turkey (Türkiye)